These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 18276610
1. Gain-of-function haplotype in the epithelial calcium channel TRPV6 is a risk factor for renal calcium stone formation. Suzuki Y, Pasch A, Bonny O, Mohaupt MG, Hediger MA, Frey FJ. Hum Mol Genet; 2008 Jun 01; 17(11):1613-8. PubMed ID: 18276610 [Abstract] [Full Text] [Related]
2. TRPV5 gene polymorphisms in renal hypercalciuria. Renkema KY, Lee K, Topala CN, Goossens M, Houillier P, Bindels RJ, Hoenderop JG. Nephrol Dial Transplant; 2009 Jun 01; 24(6):1919-24. PubMed ID: 19131347 [Abstract] [Full Text] [Related]
3. PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers. Pasch A, Frey FJ, Eisenberger U, Mohaupt MG, Bonny O. Nephrol Dial Transplant; 2008 Aug 01; 23(8):2563-70. PubMed ID: 18398019 [Abstract] [Full Text] [Related]
4. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients. Rendina D, Mossetti G, Viceconti R, Sorrentino M, Castaldo R, Manno G, Guadagno V, Strazzullo P, Nunziata V. Urology; 2004 Oct 01; 64(4):833-8. PubMed ID: 15491743 [Abstract] [Full Text] [Related]
5. TRPV6 exhibits unusual patterns of polymorphism and divergence in worldwide populations. Akey JM, Swanson WJ, Madeoy J, Eberle M, Shriver MD. Hum Mol Genet; 2006 Jul 01; 15(13):2106-13. PubMed ID: 16717058 [Abstract] [Full Text] [Related]
6. [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results]. Moyano MJ, Gómez de Tejada MJ, García Lozano R, Moruno R, Ortega R, Martí V, Sánchez Palencia R, Miranda MJ, Palma A, Pérez Cano R. Nefrologia; 2007 Jul 01; 27(6):694-703. PubMed ID: 18336098 [Abstract] [Full Text] [Related]
7. Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls. Hess B, Lippuner K, Takkinen R, Villiger L, Ackermann D, Jaeger P. Nephrol Dial Transplant; 1995 Jul 01; 10(9):1614-9. PubMed ID: 8559479 [Abstract] [Full Text] [Related]
16. TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. Lehen'kyi V, Flourakis M, Skryma R, Prevarskaya N. Oncogene; 2007 Nov 15; 26(52):7380-5. PubMed ID: 17533368 [Abstract] [Full Text] [Related]
17. Renal handling of calcium in hypercalciuric calcium oxalate nephrolithiasis. Colette C, Percheron C, Pham CT, Boniface H, Thomas N, Guiter J, Monnier L. Miner Electrolyte Metab; 1993 Nov 15; 19(6):377-84. PubMed ID: 8164620 [Abstract] [Full Text] [Related]
18. Metabolic studies in kidney stone disease. Wong SY, Slater SR, Evans RA, Mason R, Lancaster EK, Acland SM, Eade Y, Hills E, Dunstan CR. Q J Med; 1992 Mar 15; 82(299):247-58. PubMed ID: 1631259 [Abstract] [Full Text] [Related]
19. The negative effect of dexamethasone on calcium-processing gene expressions is associated with a glucocorticoid-induced calcium-absorbing disorder. Kim MH, Lee GS, Jung EM, Choi KC, Jeung EB. Life Sci; 2009 Jul 17; 85(3-4):146-52. PubMed ID: 19490920 [Abstract] [Full Text] [Related]
20. Vitamin D and calcium receptors: links to hypercalciuria. Bai S, Favus MJ. Curr Opin Nephrol Hypertens; 2006 Jul 17; 15(4):381-5. PubMed ID: 16775452 [Abstract] [Full Text] [Related] Page: [Next] [New Search]